Breaking News

Fujifilm Diosynth Opens Viral Vector Gene Therapy Facility in UK

Facility is cGMP operational for manufacturing of viral gene therapies, oncolytic viruses, and viral vaccines for clinical trials.

FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) partner for the development and manufacture of biologics, vaccines, cell and gene therapies, and oncolytic viruses, completed a new facility in Darlington, UK, which is now cGMP operational for manufacturing of viral gene therapies, oncolytic viruses, and viral vaccines for clinical trials. The new facility underscores the company’s investment in and commitment to meeting the increased demand for prod...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters